SCHEMBL5867747

SCHEMBL5867747

O=C(Nc1cc(C2CC2)n[nH]1)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.51
NPC1 O15118 6/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
MAPT P10636 4/20 0.51
ALDH1A1 P00352 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CRBN Q96SW2 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
GRM5 P41594 1/20 0.47
GRM4 Q14833 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
KDR P35968 2/20 0.44
EGFR P00533 1/20 0.44
ERBB2 P04626 1/20 0.44
MET P08581 1/20 0.44
MERTK Q12866 1/20 0.44
PKM P14618 2/20 0.44
POLB P06746 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561408 0.90 GRM4 (0.46) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL5867670 0.83 CCNA2 (0.59) RAB9ANPC1MAPTTP53
SCHEMBL5867718 0.81 SMN1; SMN2 (0.53) RAB9ANPC1SMN1; SMN2MAPTKDM4E
SCHEMBL5867800 0.81 CRACR2A (0.54) CA1CA2
SCHEMBL5867482 0.80 CCNA2 (0.64) RAB9ANPC1SMN1; SMN2MAPTPOLB
SCHEMBL5867446 0.79 CCNA2 (0.51) RAB9ANPC1SMN1; SMN2MAPTHDAC6
SCHEMBL5867954 0.79 CCNA2 (0.54) RAB9ANPC1MAPT
SCHEMBL5867690 0.79 CRACR2A (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL5867534 0.79 CCNA2 (0.62) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL5867840 0.78 TYK2 (0.46) RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034049-B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents PHARMACIA ITALIA S.P.A. (IT) 2006-04-25 US disclosed
EP-1202733-B1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-10-05 EP disclosed
EP-1202733-A4 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2003-05-14 EP disclosed
EP-1202733-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP disclosed
US-6218418-B1 THERAPY OF CELL PROLIFERATIVE DISORDERS ASSOCIATED WITH AN ALTERED CELL DEPENDENT KINASE ACTIVITY BY ADMINISTERING AMINO PYRAZOLE DERIVATIVE TO MAMMAL PHARMACIA & UPJOHN S.P.A (IT) 2001-04-17 US disclosed
WO-2001012189-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-02-22 WO disclosed